Tomoyuki Fujioka

The mechanism of lack of hypocholesterolemic effects of pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rats

Tomoyuki Fujioka, Futoshi Nara, Yoshio Tsujita et al. · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 1995 · 94 citations

Hypocholesterolemic Effects, Metabolic Syndrome, Pravastatin Sodium +13

Structure of complestatin, a very strong inhibitor of protease activity of complement in the human complement system

Haruo Seto, Tomoyuki Fujioka, Kazuo Furihata et al. · Tetrahedron Letters · 1989 · 69 citations

Complement System, Autoimmune Disease, Biochemistry +8

Alutacenoic Acids A and B, Rare Naturally Occurring Cyclopropenone Derivatives Isolated from Fungi:  Potent Non-Peptide Factor XIIIa Inhibitors

Hiroshi Kogen, Toshihiro Kiho, Keiko Tago et al. · Journal of the American Chemical Society · 2000 · 47 citations

Molecular Pharmacology, Medicinal Chemistry, Alutacenoic Acids A +14

Epi-cochlioquinone A, a Novel Acyl-CoA: Cholesterol Acyltransferase Inhibitor Produced by Stachybotrys bisbyi.

Tomoyuki Fujioka, Keiko Yao, KIYOSHI HAMANO et al. · The Journal of Antibiotics · 1996 · 41 citations · Full text

Schizostatin, a Novel Squalene Synthase Inhibitor Produced by the Mushroom, Schizophyllum commune. I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Biological Activities.

Tatsuo Tanimoto, Kaori Onodera, Tsuyoshi Hosoya et al. · The Journal of Antibiotics · 1996 · 33 citations · Full text